IRRAS Announces Engagement and Education Symposium at Important Upcoming Neurosurgery Conference

  • IRRAS to be presented at the upcoming Congress of Neurosurgeons (CNS) Annual Meeting San Francisco, Californiadevout October 8-12, 2022and Neurocritical Care Society (NCS) Annual Meeting San Antonio, Texassuperior October 17-21, 2022.
  • IRRAS will participate in “Neurotrauma across the lifespan and around the world“Central Nervous System Symposium Sunday, October 9, 2022start with 0800 Pacific Timewhich will provide workshop attendees with hands-on product training.
  • During CNS, Dr. Benan Rezai Jaromia neurosurgeon University of Helsinki Hospital, will present a scientific poster titled “Active Cerebrospinal Fluid (CSF) Exchange and Removal of Subarachnoid Hemorrhage (SAH) to Reduce Shunt Dependence”.

Stockholm, October May 2022 /PRNewswire/ — IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of neurocritical care innovations, today announced plans to participate in the upcoming annual meeting of the Congress of Neurosurgeons in the United States San Francisco, Californiadevout October 8-12, 2022and Neurocritical Care Association San Antonio, Texasdevout October 17-21, 2022.

Both conferences are highly regarded and highly engaged conferences that bring together neurosurgeons, neurointensivists and other healthcare professionals from around the world to enhance health and improve lives by advancing neurosurgical education and scientific exchange.

During CNS, IRRAS will be exhibiting at booth #332, and at NCS, the IRRAS team will meet attendees and provide IRRA demos at booth #513flow and the Hummingbird Neuromonitoring product line. Attendees at both conferences are encouraged to visit the IRRAS booth to learn more.

Also at the CNS, IRRAS will participate in a full-day workshop where international experts will present their unique perspectives on neurotrauma management to integrate best practice and emerging evidence to optimize outcomes. The workshop will include a product demonstration station, IRRAflow, the world’s first active fluid exchange system, and Hummingbird ICP’s advanced line of neuromonitoring products will be showcased. Details are as follows.

Seminar Details

Title: “SYM11: Neurotrauma across the lifespan and around the world”

date: Sunday, October 9, 2022

time: 0800 to 1615 Pacific Daylight Time

Location: Moscone Center, Rome 2009

In addition to attending neurotrauma seminars in the CNS, clinical data on the use of IRRAflow The system will also be introduced. PhD. Benan Rezai Jaromia neurosurgeon University of Helsinki Hospitals, will present a poster titled “Positive CSF Exchange and SAH Removal to Reduce Triage Dependence”, which will be available for in-person and online review.

“October will be an exciting month for IRRAS and we are delighted to have the opportunity to partner with the Congress of Neurosurgeons and the Neurocritical Care Society for their upcoming annual meeting,” said Will Martin, President and CEO of IRRAS. “Our team looks forward to meeting attendees in person at these two important conferences to build our IRRA brand awarenessflow and Hummingbird product lines, and highlights the growing commercial adoption and clinical evidence base. ”


IRRAS is a global healthcare company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops and commercializes neurocritical care products that transform patient outcomes and reduce overall cost of care by addressing complications associated with current treatments. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product line is supplied to hospitals worldwide through its direct sales organization around the world U.S. And select European countries as well as an international network of distribution partners.

IRRAS is headquartered in Stockholm, SwedenThe company office is located at Munich Germanyand San Diego, California, U.S. For more information, visit

IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).

For more information, please contact:

Sten Gustafsson
Director of Investor Relations
[email protected]
+46 102 11 5172

This information has been passed through the agency of the above contact person at October 5, 20228:30 (CET).

This information is provided to you by Cision,c3642706


Source link